
Abu Dhabi wrapped up the activities of “DoH Innovation Week 2023”, which included the announcement of the winners of the Healthcare Research and Innovation Grant and a series of panel discussions that tapped into several areas of innovation, such as, supporting entrepreneurs, design thinking, Artificial Intelligence (AI), and the National Innovation Strategy. This comes as part of DoH’s efforts to cement Abu Dhabi’s position as a leading destination for innovation in healthcare and a hub life sciences.
Recent Posts

Breakthrough in cemdisiran gMG treatment Advances Regulatory Landscape
Cemdisiran gMG treatment has cleared a critical hurdle after the FDA and EMA accepted Regeneron’s regulatory submissions for review in anti-AChR antibody-positive generalized myasthenia gravis (gMG). The investigational siRNA therapy targeting complement protein C5 could become the first subcutan...

Advancements in Breast Cancer Treatment Following Trodelvy ADC Approval
The Trodelvy ADC approval by the European Commission delivers the first antibody-drug conjugate approved for first-line use in adults with unresectable or metastatic triple-negative breast cancer who are ineligible for PD-1 or PD-L1 inhibitors. This

Cemiplimab Cervical Cancer Access Navigating Treatment and Value
Cemiplimab Cervical Cancer Access has been endorsed by NICE for adults with recurrent or metastatic cervical cancer that has progressed after platinum-based chemotherapy, provided patients have not previously received immunotherapy. The final draft guidance confirms that this PD-1 inhibitor deliv...